Amazon hires former FDA chief health informatics officer

Amazon has hired a former FDA chief health informatics officer to work on its secretive health business, according to CNBC.

The company has been steadily moving towards the healthcare industry, recently announcing a partnership with Berkshire Hathaway and JPMorgan Chase to offer its employees lower healthcare costs through technology solutions.

Now, Amazon has hired Taha Kass-Hout, a former FDA chief health informatics officer responsible for the openFDA project which offers easy access to structured datasets for medical researchers.

According to CNBC, Kass-Hout’s role will focus on developing healthcare projects and he will work alongside Babak Parvix, a former Google X director who joined Amazon as vice president in 2014.

Kass-Hout worked at the FDA from 2013 to 2016 where he held a number of positions including chief technology officer. Prior to that he worked at the Centers for Disease Control and Prevention as director of health informatics and solutions. Most recently, he worked at Trinity Health as SVP and chief digital health & intelligence officer.

On his LinkedIn profile, Kass-Hout states he is a ‘physician executive empowering consumers via sustainable health data ecosystems’.

Interestingly, it could mean that Amazon will be following moves by the likes of Apple into offering consumers access to health data.

Given his experience in the FDA, CNBC state that it’s possible Kass-Hout could help Amazon through the stages of regulation, helping it bring new health technology or software to market.





Reece Armstrong is a reporter for Digital Health Age. Coming from the North East of England, Reece has an MA in Media & Journalism and a BA in Popular & Contemporary Music from Newcastle University. Reach him on Twitter or email via:

'Amazon hires former FDA chief health informatics officer' has no comments

Be the first to comment this post!

Would you like to share your thoughts?

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

© 2019 Rapid Life Sciences Ltd, a Rapid News Group Company. All Rights Reserved.

Privacy policy

Terms and conditions